AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2011
Mar 2, 2011
29875_dirs_2011-03-02_bbaa39d2-94b4-4e5c-893f-080695d76c6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2011-02-28
Reporting Person: HEARD MARIAN L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-28 | Common Stock | M | 30000 | $14.9624 | Acquired | 31716.666 | Direct |
| 2011-02-28 | Common Stock | F | 20371 | $33.22 | Disposed | 11345.666 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-28 | Stock Option | $14.9625 | M | 30000 | Disposed | 2012-01-02 | Common Stock (30000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Share Credits | $0 | Common Stock (73637.0399) | 73637.0399 | Direct |
Footnotes
F1: Surrender of shares in payment of option strike price and estimated taxes due.
F2: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees, all at market price pursuant to the 1997 Incentive Compensation Plan, and payable pursuant to Insiders election.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Declaration of Voting Results & Voting Rights Announcements
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3